EvokAI Creative Labs Inc (TSE:OKAI)
TSXV:OKAI
Canadian Market

EvokAI Creative Labs Inc (OKAI) Stock Price & Analysis

1 Followers

OKAI Stock Chart & Stats

Day’s RangeC$0 - C$0
52-Week RangeC$0.06 - C$2.00
Previous CloseC$0.07
Volume1.50K
Average Volume (3M)9.23K
Market Cap
C$2.82M
Enterprise ValueC$3.27M
Total Cash (Recent Filing)$322.02K
Total Debt (Recent Filing)$768.66K
Price to Earnings (P/E)
Beta-0.50
May 30, 2024
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.11
Shares Outstanding76,054,930
10 Day Avg. Volume1,510
30 Day Avg. Volume9,233
Standard Deviation0.45
R-Squared0.10
Alpha-0.00148
Financial Highlights & Ratios
Price to Book (P/B)15.46
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-3.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-0.19
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

30.59%0.00%0.00%69.41%
30.59%
Insiders
0.00% Other Institutional Investors
69.41% Public Companies and
Individual Investors

OKAI FAQ

What was EvokAI Creative Labs Inc’s price range in the past 12 months?
EvokAI Creative Labs Inc lowest stock price was C$0.06 and its highest was C$2.00 in the past 12 months.
    What is EvokAI Creative Labs Inc’s market cap?
    Currently, no data Available
    When is EvokAI Creative Labs Inc’s upcoming earnings report date?
    EvokAI Creative Labs Inc’s upcoming earnings report date is May 30, 2024 which is 55 days ago.
      How were EvokAI Creative Labs Inc’s earnings last quarter?
      EvokAI Creative Labs Inc released its earnings results on Apr 29, 2024. The company reported -C$0.008 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.008.
        Is EvokAI Creative Labs Inc overvalued?
        According to Wall Street analysts EvokAI Creative Labs Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does EvokAI Creative Labs Inc pay dividends?
          EvokAI Creative Labs Inc does not currently pay dividends.
          What is EvokAI Creative Labs Inc’s EPS estimate?
          EvokAI Creative Labs Inc’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does EvokAI Creative Labs Inc have?
          EvokAI Creative Labs Inc has 40,320,484 shares outstanding.
            What happened to EvokAI Creative Labs Inc’s price movement after its last earnings report?
            EvokAI Creative Labs Inc reported an EPS of -C$0.008 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
              Which hedge fund is a major shareholder of EvokAI Creative Labs Inc?
              Currently, no hedge funds are holding shares in TSE:OKAI
              ---

              EvokAI Creative Labs Inc Stock Smart Score

              10
              Unlock Smart Score
              1
              2
              3
              4
              5
              6
              7
              8
              9
              10

              Technicals

              SMA
              Negative
              20 days / 200 days
              Momentum
              -96.50%
              12-Months-Change

              Fundamentals

              Return on Equity
              Trailing 12-Months
              Asset Growth
              4156.81%
              Trailing 12-Months

              Company Description

              EvokAI Creative Labs Inc

              EvokAI Creative Labs Inc is a medtech artificial-intelligence-powered company. It deploys machine learning models to search medical data and uncover insights to help improve health outcomes, patient experiences, drug development, preclinical and clinical decisions, and provide more accurate diagnoses. EvokAI tailors its AI algorithms across the whole healthcare system, from hospitals, private clinics, research institutions, pharmaceutical companies, contract research organizations to medical professionals, patients, healthy individuals aiming at preventing and early detecting any kind of disease and beyond, protecting the aging genome.
              ---
              Similar Stocks
              Company
              Price & Change
              Follow
              AnalytixInsight
              Sangoma Technologies
              Victory Square Technologies Inc
              Martello Technologies Group Inc
              Popular Stocks
              ---
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis